Literature DB >> 12165184

Integrating patient preferences in clinical trials: a pilot study of acupuncture versus midazolam for gastroscopy.

Dieter Melchart1, Hans-Gerhard Steger, Klaus Linde, Karina Makarian, Ziad Hatahet, Rainer Brenke, Reinhard Saller.   

Abstract

BACKGROUND AND OBJECTIVES: Patient preferences play an important role when choosing between different treatment options and may have an influence on outcome. We performed a study to investigate (1) to what extent patients make use of the offer to receive acupuncture as a pretreatment for gastroscopy, (2) whether this is perceived as being as effective as sedation, and (3) whether characteristics and outcomes differ between patients giving consent to random allocation and patients choosing their pretreatment.
DESIGN: Partially randomized patient preference trial. Patients who gave consent to randomization were allocated randomly while patients who had a preference received the treatment of their choice. PATIENTS: One hundred and six (106) inpatients of a district hospital in southern Germany undergoing gastroscopy for diagnostic purposes.
INTERVENTIONS: Pretreatment with a sedative (midazolam) or acupuncture. MAIN OUTCOME MEASURE: Patient's overall assessment on a visual analogue scale (VAS).
RESULTS: Twenty-eight (28) patients (26%) agreed to be randomized, 21 (20%) chose acupuncture, 51 (47%) midazolam, and 8 (7%) did not want pretreatment. Patients receiving midazolam rated the examination as slightly less troublesome than those receiving acupuncture. Oxygen saturation, blood pressure, and heart rate were significantly lower in patients receiving midazolam. Characteristics and outcomes of randomized and nonrandomized patients did not differ significantly.
CONCLUSIONS: Because of the low number of patients giving consent to random allocation conclusions on effectiveness are difficult to draw. The partially randomized patient preference design is recommended for use in future trials of acupuncture for gastroscopy. Such trials should be performed in an outpatient setting.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165184     DOI: 10.1089/10755530260127952

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  6 in total

1.  Bispectral index evaluation of the sedative effect of acupuncture in healthy volunteers.

Authors:  Luca Cabrini; Luigi Gioia; Marco Gemma; Valeria Cedrati; Martina Crivellari
Journal:  J Clin Monit Comput       Date:  2006-09-19       Impact factor: 2.502

Review 2.  Outcomes for patients with the same disease treated inside and outside of randomized trials: a systematic review and meta-analysis.

Authors:  Natasha Fernandes; Dianne Bryant; Lauren Griffith; Mohamed El-Rabbany; Nisha M Fernandes; Crystal Kean; Jacquelyn Marsh; Siddhi Mathur; Rebecca Moyer; Clare J Reade; John J Riva; Lyndsay Somerville; Neera Bhatnagar
Journal:  CMAJ       Date:  2014-09-29       Impact factor: 8.262

3.  Does random treatment assignment cause harm to research participants?

Authors:  Cary P Gross; Harlan M Krumholz; Gretchen Van Wye; Ezekiel J Emanuel; David Wendler
Journal:  PLoS Med       Date:  2006-06       Impact factor: 11.069

4.  Effect of electroacupuncture on discomfort during gastroscopy: a study protocol for a randomized controlled trial.

Authors:  Binyu Yu; Philippa Jemma Hazlewood; Xuan Yin; Shanshan Li; Hongyu Yue; Kun Xu; Shifen Xu; Yiqun Mi
Journal:  Trials       Date:  2022-04-27       Impact factor: 2.728

Review 5.  Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate.

Authors:  Gunn Elisabeth Vist; Dianne Bryant; Lyndsay Somerville; Trevor Birminghem; Andrew D Oxman
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

6.  Acupuncture to improve tolerance of diagnostic esophagogastroduodenoscopy in patients without systemic sedation: results of a single-center, double-blinded, randomized controlled trial (DRKS00000164).

Authors:  Anja Schaible; Katja Schwan; Thomas Bruckner; Konstanze Plaschke; Markus W Büchler; Markus Weigand; Peter Sauer; Christian Bopp; Phillip Knebel
Journal:  Trials       Date:  2016-07-26       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.